Skip to main content
    M

    MiMedx Group Inc (MDXG)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.18
    -0.03 (-0.93%)

    Market Cap: $468.42M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    MiMedx Group Inc (MDXG) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    MiMedx Group (MDXG) trades at 106.0x trailing earnings and 1.5x sales. Its P/S of 1.5x is below its 5-year median of 2.5x. Its forward P/E is 19.5x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 443.6% higher over the next year. Its free cash flow yield is 4.1%.

    MultipleValue
    P/E (trailing)106.0x
    Forward P/E19.5x
    Price to sales1.5x
    Price to book2.2x
    Price to FCF24.3x
    EV/FCF17.9x
    PEG2.9
    FCF yield4.1%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 42.3% below 2.6x.

    MultipleCurrent5-year median10-year median
    P/S1.5x2.5x2.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 7 of the 10 year ends shown that have a P/E, its P/E ranged from 15.4x in 2025 to 100.9x in 2020. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$6.7715.4x2.4x4.0x
    2024$9.6233.2x4.1x7.4x
    2023$8.7726.1x3.4x9.1x
    2022$2.78N/A1.2xN/A
    2021$6.04N/A2.8x7.4x
    2020$9.08100.9x4.0x10.8x
    2019$7.5836.1x2.7x16.2x
    2018$1.79N/A0.5x3.8x
    2017$12.6139.4x4.3x19.4x
    2016$8.8640.3x4.3x7.6x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About MDXG

    What is MDXG's forward P/E ratio?

    MiMedx Group has a forward P/E ratio of 19.5x.

    Is MDXG stock overvalued?

    GNG's valuation label for MDXG is Undervalued.

    What is MDXG's price to sales ratio?

    MiMedx Group has a price to sales ratio of 1.5x.

    What is MDXG's PEG ratio?

    MiMedx Group has a PEG ratio of 2.9.